Inflammatory Bowel Disease Therapy Market, Global Outlook and Forecast 2023-2028

Report ID: 1371510 | Published Date: Jan 2025 | No. of Page: 66 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Inflammatory Bowel Disease Therapy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Inflammatory Bowel Disease Therapy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Inflammatory Bowel Disease Therapy Overall Market Size
    2.1 Global Inflammatory Bowel Disease Therapy Market Size: 2021 VS 2028
    2.2 Global Inflammatory Bowel Disease Therapy Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Inflammatory Bowel Disease Therapy Players in Global Market
    3.2 Top Global Inflammatory Bowel Disease Therapy Companies Ranked by Revenue
    3.3 Global Inflammatory Bowel Disease Therapy Revenue by Companies
    3.4 Top 3 and Top 5 Inflammatory Bowel Disease Therapy Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Inflammatory Bowel Disease Therapy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Inflammatory Bowel Disease Therapy Players in Global Market
        3.6.1 List of Global Tier 1 Inflammatory Bowel Disease Therapy Companies
        3.6.2 List of Global Tier 2 and Tier 3 Inflammatory Bowel Disease Therapy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Inflammatory Bowel Disease Therapy Market Size Markets, 2021 & 2028
        4.1.2 Ulcerative Colitis
        4.1.3 Crohns Disease
        4.1.4 Others
    4.2 By Type - Global Inflammatory Bowel Disease Therapy Revenue & Forecasts
        4.2.1 By Type - Global Inflammatory Bowel Disease Therapy Revenue, 2017-2022
        4.2.2 By Type - Global Inflammatory Bowel Disease Therapy Revenue, 2023-2028
        4.2.3 By Type - Global Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Inflammatory Bowel Disease Therapy Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Medical Research Organization
        5.1.4 Other
    5.2 By Application - Global Inflammatory Bowel Disease Therapy Revenue & Forecasts
        5.2.1 By Application - Global Inflammatory Bowel Disease Therapy Revenue, 2017-2022
        5.2.2 By Application - Global Inflammatory Bowel Disease Therapy Revenue, 2023-2028
        5.2.3 By Application - Global Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Inflammatory Bowel Disease Therapy Market Size, 2021 & 2028
    6.2 By Region - Global Inflammatory Bowel Disease Therapy Revenue & Forecasts
        6.2.1 By Region - Global Inflammatory Bowel Disease Therapy Revenue, 2017-2022
        6.2.2 By Region - Global Inflammatory Bowel Disease Therapy Revenue, 2023-2028
        6.2.3 By Region - Global Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Inflammatory Bowel Disease Therapy Revenue, 2017-2028
        6.3.2 US Inflammatory Bowel Disease Therapy Market Size, 2017-2028
        6.3.3 Canada Inflammatory Bowel Disease Therapy Market Size, 2017-2028
        6.3.4 Mexico Inflammatory Bowel Disease Therapy Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Inflammatory Bowel Disease Therapy Revenue, 2017-2028
        6.4.2 Germany Inflammatory Bowel Disease Therapy Market Size, 2017-2028
        6.4.3 France Inflammatory Bowel Disease Therapy Market Size, 2017-2028
        6.4.4 U.K. Inflammatory Bowel Disease Therapy Market Size, 2017-2028
        6.4.5 Italy Inflammatory Bowel Disease Therapy Market Size, 2017-2028
        6.4.6 Russia Inflammatory Bowel Disease Therapy Market Size, 2017-2028
        6.4.7 Nordic Countries Inflammatory Bowel Disease Therapy Market Size, 2017-2028
        6.4.8 Benelux Inflammatory Bowel Disease Therapy Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Inflammatory Bowel Disease Therapy Revenue, 2017-2028
        6.5.2 China Inflammatory Bowel Disease Therapy Market Size, 2017-2028
        6.5.3 Japan Inflammatory Bowel Disease Therapy Market Size, 2017-2028
        6.5.4 South Korea Inflammatory Bowel Disease Therapy Market Size, 2017-2028
        6.5.5 Southeast Asia Inflammatory Bowel Disease Therapy Market Size, 2017-2028
        6.5.6 India Inflammatory Bowel Disease Therapy Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Inflammatory Bowel Disease Therapy Revenue, 2017-2028
        6.6.2 Brazil Inflammatory Bowel Disease Therapy Market Size, 2017-2028
        6.6.3 Argentina Inflammatory Bowel Disease Therapy Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Inflammatory Bowel Disease Therapy Revenue, 2017-2028
        6.7.2 Turkey Inflammatory Bowel Disease Therapy Market Size, 2017-2028
        6.7.3 Israel Inflammatory Bowel Disease Therapy Market Size, 2017-2028
        6.7.4 Saudi Arabia Inflammatory Bowel Disease Therapy Market Size, 2017-2028
        6.7.5 UAE Inflammatory Bowel Disease Therapy Market Size, 2017-2028
7 Players Profiles
    7.1 Johnson & Johnson
        7.1.1 Johnson & Johnson Corporate Summary
        7.1.2 Johnson & Johnson Business Overview
        7.1.3 Johnson & Johnson Inflammatory Bowel Disease Therapy Major Product Offerings
        7.1.4 Johnson & Johnson Inflammatory Bowel Disease Therapy Revenue in Global Market (2017-2022)
        7.1.5 Johnson & Johnson Key News
    7.2 AbbVie
        7.2.1 AbbVie Corporate Summary
        7.2.2 AbbVie Business Overview
        7.2.3 AbbVie Inflammatory Bowel Disease Therapy Major Product Offerings
        7.2.4 AbbVie Inflammatory Bowel Disease Therapy Revenue in Global Market (2017-2022)
        7.2.5 AbbVie Key News
    7.3 Takeda Pharmaceutical Company
        7.3.1 Takeda Pharmaceutical Company Corporate Summary
        7.3.2 Takeda Pharmaceutical Company Business Overview
        7.3.3 Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Major Product Offerings
        7.3.4 Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Revenue in Global Market (2017-2022)
        7.3.5 Takeda Pharmaceutical Company Key News
    7.4 Abbott
        7.4.1 Abbott Corporate Summary
        7.4.2 Abbott Business Overview
        7.4.3 Abbott Inflammatory Bowel Disease Therapy Major Product Offerings
        7.4.4 Abbott Inflammatory Bowel Disease Therapy Revenue in Global Market (2017-2022)
        7.4.5 Abbott Key News
    7.5 Celgene Corporation
        7.5.1 Celgene Corporation Corporate Summary
        7.5.2 Celgene Corporation Business Overview
        7.5.3 Celgene Corporation Inflammatory Bowel Disease Therapy Major Product Offerings
        7.5.4 Celgene Corporation Inflammatory Bowel Disease Therapy Revenue in Global Market (2017-2022)
        7.5.5 Celgene Corporation Key News
    7.6 Innovate Biopharma
        7.6.1 Innovate Biopharma Corporate Summary
        7.6.2 Innovate Biopharma Business Overview
        7.6.3 Innovate Biopharma Inflammatory Bowel Disease Therapy Major Product Offerings
        7.6.4 Innovate Biopharma Inflammatory Bowel Disease Therapy Revenue in Global Market (2017-2022)
        7.6.5 Innovate Biopharma Key News
    7.7 Cosmo Pharmaceuticals
        7.7.1 Cosmo Pharmaceuticals Corporate Summary
        7.7.2 Cosmo Pharmaceuticals Business Overview
        7.7.3 Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Major Product Offerings
        7.7.4 Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Revenue in Global Market (2017-2022)
        7.7.5 Cosmo Pharmaceuticals Key News
    7.8 Gilead Sciences
        7.8.1 Gilead Sciences Corporate Summary
        7.8.2 Gilead Sciences Business Overview
        7.8.3 Gilead Sciences Inflammatory Bowel Disease Therapy Major Product Offerings
        7.8.4 Gilead Sciences Inflammatory Bowel Disease Therapy Revenue in Global Market (2017-2022)
        7.8.5 Gilead Sciences Key News
    7.9 Pfizer
        7.9.1 Pfizer Corporate Summary
        7.9.2 Pfizer Business Overview
        7.9.3 Pfizer Inflammatory Bowel Disease Therapy Major Product Offerings
        7.9.4 Pfizer Inflammatory Bowel Disease Therapy Revenue in Global Market (2017-2022)
        7.9.5 Pfizer Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Inflammatory Bowel Disease Therapy Market Opportunities & Trends in Global Market
    Table 2. Inflammatory Bowel Disease Therapy Market Drivers in Global Market
    Table 3. Inflammatory Bowel Disease Therapy Market Restraints in Global Market
    Table 4. Key Players of Inflammatory Bowel Disease Therapy in Global Market
    Table 5. Top Inflammatory Bowel Disease Therapy Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Inflammatory Bowel Disease Therapy Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Inflammatory Bowel Disease Therapy Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Inflammatory Bowel Disease Therapy Product Type
    Table 9. List of Global Tier 1 Inflammatory Bowel Disease Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Inflammatory Bowel Disease Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Inflammatory Bowel Disease Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Inflammatory Bowel Disease Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Inflammatory Bowel Disease Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Inflammatory Bowel Disease Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Inflammatory Bowel Disease Therapy Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Inflammatory Bowel Disease Therapy Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2023-2028
    Table 30. Johnson & Johnson Corporate Summary
    Table 31. Johnson & Johnson Inflammatory Bowel Disease Therapy Product Offerings
    Table 32. Johnson & Johnson Inflammatory Bowel Disease Therapy Revenue (US$, Mn), (2017-2022)
    Table 33. AbbVie Corporate Summary
    Table 34. AbbVie Inflammatory Bowel Disease Therapy Product Offerings
    Table 35. AbbVie Inflammatory Bowel Disease Therapy Revenue (US$, Mn), (2017-2022)
    Table 36. Takeda Pharmaceutical Company Corporate Summary
    Table 37. Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Product Offerings
    Table 38. Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Revenue (US$, Mn), (2017-2022)
    Table 39. Abbott Corporate Summary
    Table 40. Abbott Inflammatory Bowel Disease Therapy Product Offerings
    Table 41. Abbott Inflammatory Bowel Disease Therapy Revenue (US$, Mn), (2017-2022)
    Table 42. Celgene Corporation Corporate Summary
    Table 43. Celgene Corporation Inflammatory Bowel Disease Therapy Product Offerings
    Table 44. Celgene Corporation Inflammatory Bowel Disease Therapy Revenue (US$, Mn), (2017-2022)
    Table 45. Innovate Biopharma Corporate Summary
    Table 46. Innovate Biopharma Inflammatory Bowel Disease Therapy Product Offerings
    Table 47. Innovate Biopharma Inflammatory Bowel Disease Therapy Revenue (US$, Mn), (2017-2022)
    Table 48. Cosmo Pharmaceuticals Corporate Summary
    Table 49. Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Product Offerings
    Table 50. Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Revenue (US$, Mn), (2017-2022)
    Table 51. Gilead Sciences Corporate Summary
    Table 52. Gilead Sciences Inflammatory Bowel Disease Therapy Product Offerings
    Table 53. Gilead Sciences Inflammatory Bowel Disease Therapy Revenue (US$, Mn), (2017-2022)
    Table 54. Pfizer Corporate Summary
    Table 55. Pfizer Inflammatory Bowel Disease Therapy Product Offerings
    Table 56. Pfizer Inflammatory Bowel Disease Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Inflammatory Bowel Disease Therapy Segment by Type in 2021
    Figure 2. Inflammatory Bowel Disease Therapy Segment by Application in 2021
    Figure 3. Global Inflammatory Bowel Disease Therapy Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Inflammatory Bowel Disease Therapy Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Inflammatory Bowel Disease Therapy Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Inflammatory Bowel Disease Therapy Revenue in 2021
    Figure 8. By Type - Global Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028
    Figure 12. US Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028
    Figure 16. Germany Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 17. France Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028
    Figure 24. China Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 28. India Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028
    Figure 30. Brazil Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028
    Figure 33. Turkey Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
    Figure 37. Johnson & Johnson Inflammatory Bowel Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. AbbVie Inflammatory Bowel Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Abbott Inflammatory Bowel Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Celgene Corporation Inflammatory Bowel Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Innovate Biopharma Inflammatory Bowel Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Gilead Sciences Inflammatory Bowel Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Pfizer Inflammatory Bowel Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
66
Frequently Asked Questions
Inflammatory Bowel Disease Therapy Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Inflammatory Bowel Disease Therapy Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Inflammatory Bowel Disease Therapy Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports